Skip to main content
Interactive

Learn about COPD-associated eosinophilic inflammation and how it may influence treatment. 

10 slides & 4 questions
Interactive

How real is ACOS as a diagnosis?

10 slides & 5 questions
Interactive

Review key results and reanalyses from clinical trials investigating combination therapy in COPD.

11 slides & 5 questions
Interactive

Learn about the components of eCigarettes and their potential dangers.

10 slides & 4 questions
Interactive

This module covers the latest news from the ATS 2016 on COPD pathogenesis and lung cell structure.

9 slides & 4 questions
Downloadable resource

Build your knowledge on the potential and potential pitfalls of eCigarettes with this Hot Topic from the ATS 2016.

4 pages
Downloadable resource

Stay up-to-date on new insights into the pathophysiology of COPD with this Hot Topic from the ATS 2016.

3 pages
Downloadable resource

Learn more about eosinophils and COPD in this Hot Topic from the ATS 2016.

2 pages
Downloadable resource

Get more details on the new data presented at the ATS 2016 on combination therapy in this Hot Topic.

4 pages

Disclaimer

Using this link will let you leave a website of Boehringer Ingelheim International GmbH (“BI”) or to a different domain under the control of BI. In the event that the linked site is not under the control of BI but under the control of a third party or an affiliate in the Boehringer Ingelheim group of companies, BI shall not be responsible for the contents, processing of personal data of any linked site or any link contained in a linked site, or any changes or updates to such sites. This link is provided to you only as a convenience, and the inclusion of any link does not imply endorsement by BI of the site.

Continue

Welcome to RespiratoryXchange for international healthcare professionals outside the United States of America.

This website is an international information resource intended for international healthcare professionals outside the United States of America (US) who are interested in medical information on respiratory diseases such as COPD.

While the Internet serves a global community, the pharmaceutical industry is subject to country-specific regulatory considerations. This means that the registration status and approved product labels of the mentioned medicinal products may not be the same in different countries. Please refer to your local prescribing information for full details on the respective medicinal products.

By clicking on the link below you are declaring and confirming that you are a healthcare professional outside the United States of America and have read and understood this disclaimer.

I accept Leave website Go to website for healthcare professionals in the US